Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study.
Clinical trial NCT02629536 · UNKNOWN
Trial details
- NCT number
- NCT02629536
- Sponsor
- University of Notre Dame Australia
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-03-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.